A shipment of Sputnik V ingredient, as well as more Pfizer vaccines arrive in Serbia

  • 0
Sputnik V vakicna koronavirus Photo: Tanjug/AP

A significant amount of the ingredient used in the production of the Russian Sputnik V vaccine was delivered to Serbia today, to the Torlak Institute in Belgrade, Tanjug has learned.

The airplane with the shipment, which arrived from the Generium factory in the Vladimir region of Russia, landed at Belgrade's Nikola Tesla airport at around 2 pm.

Minister and President of the Intergovernmental Committee for Cooperation with Russia Nenad Popovic said on Sunday that this is a quantity of the substance sufficient for the production of more than 250,000 doses of component 1.

"After ten days, according to announcements from our Russian partners, a substance for the production of the same amount of vaccine's component 2 should be delivered to Serbia. We expect that Torlak will have about 550,000 Sputnik V component 1 and component 2 vaccines in the next two weeks," Popovic said in a statement.

According to him, once the vaccine has been produced in Torlak, 18 samples from each batch will be sent to the Russian Gamaleya Institute where they will be checked, and after that the vaccines will be available on the market.

Popovic said that the ingredients will regularly arrive in Serbia according to the dynamic determined by the Serbian and Russian sides, until the agreement, which, in the initial phase, envisages production of four million vaccines, has been completed.

New delivery of Pfizer vaccines

The Ministry of Health announced that a new, regular delivery of Pfizer-Biontech vaccines against coronavirus arrived in Serbia today.

32,760 doses have been shipped to Serbia, a statement said.

The vaccines have been transported to the Torlak Institute.

(Telegraf.rs)

Video: Tzv. kosovska policija upala u zgradu opštine Gračanica

Podelite vest:

Pošaljite nam Vaše snimke, fotografije i priče na broj telefona +381 64 8939257 (WhatsApp / Viber / Telegram).

Telegraf.rs zadržava sva prava nad sadržajem. Za preuzimanje sadržaja pogledajte uputstva na stranici Uslovi korišćenja.

Comments

Da li želite da dobijate obaveštenja o najnovijim vestima?

Možda kasnije
DA